These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 29079483

  • 1. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
    Alizadeh F, Taefnia AM, Haghdani S.
    J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
    [Abstract] [Full Text] [Related]

  • 2. Hydronephrosis: Comparison of extrinsic vessel versus intrinsic ureteropelvic junction obstruction groups and a plea against the vascular hitch procedure.
    Menon P, Rao KL, Sodhi KS, Bhattacharya A, Saxena AK, Mittal BR.
    J Pediatr Urol; 2015 Apr; 11(2):80.e1-6. PubMed ID: 25794866
    [Abstract] [Full Text] [Related]

  • 3. Laparoscopic pyeloplasty versus open pyeloplasty for recurrent ureteropelvic junction obstruction in children.
    Abdel-Karim AM, Fahmy A, Moussa A, Rashad H, Elbadry M, Badawy H, Hammady A.
    J Pediatr Urol; 2016 Dec; 12(6):401.e1-401.e6. PubMed ID: 27614698
    [Abstract] [Full Text] [Related]

  • 4. The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis.
    Atar A, Oktar T, Kucukgergin C, Kalelioglu I, Seckin S, Ander H, Ziylan O, Kadioglu TC.
    J Pediatr Urol; 2015 Jun; 11(3):133.e1-5. PubMed ID: 25824879
    [Abstract] [Full Text] [Related]

  • 5. Laparoscopic treatment of ureteropelvic junction obstruction in five pediatric cases of pelvic kidneys.
    Muller CO, Blanc T, Peycelon M, El Ghoneimi A.
    J Pediatr Urol; 2015 Dec; 11(6):353.e1-5. PubMed ID: 26233554
    [Abstract] [Full Text] [Related]

  • 6. Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children.
    Kajbafzadeh AM, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P.
    J Urol; 2010 Jun; 183(6):2353-60. PubMed ID: 20400153
    [Abstract] [Full Text] [Related]

  • 7. Can urinary caspase-3 and cytochrome c levels be used as predictive biomarkers in the management of unilateral antenatal hydronephrosis?
    Zeybek SG, Selvi İ, Oktar T, Dönmez Mİ, Ziylan O, Seçkin Ş, Küçükgergin C.
    Int Urol Nephrol; 2024 Aug; 56(8):2459-2466. PubMed ID: 38494584
    [Abstract] [Full Text] [Related]

  • 8. Urinary NGAL levels correlate with differential renal function in patients with ureteropelvic junction obstruction undergoing pyeloplasty.
    Cost NG, Noh PH, Devarajan P, Ivancic V, Reddy PP, Minevich E, Bennett M, Haffner C, Schulte M, DeFoor WR.
    J Urol; 2013 Oct; 190(4 Suppl):1462-7. PubMed ID: 23791906
    [Abstract] [Full Text] [Related]

  • 9. Urinary biomarkers in hydronephrosis.
    Madsen MG.
    Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
    [Abstract] [Full Text] [Related]

  • 10. Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels.
    Mohammadjafari H, Rafiei A, Kosaryan M, Yeganeh Y, Hosseinimehr SJ.
    Biomark Med; 2014 Feb; 8(10):1199-206. PubMed ID: 25525980
    [Abstract] [Full Text] [Related]

  • 11. Equivocal ureteropelvic junction obstruction on diuretic renogram--should minimally invasive pyeloplasty be offered to symptomatic patients?
    Ozayar A, Friedlander JI, Shakir NA, Gahan JC, Cadeddu JA, Morgan MS.
    J Urol; 2015 Apr; 193(4):1278-82. PubMed ID: 25444983
    [Abstract] [Full Text] [Related]

  • 12. Hydronephrosis and crossing vessels in children: Optimization of diagnostic-therapeutic pathway and analysis of color Doppler ultrasound and magnetic resonance urography diagnostic accuracy.
    Wong MCY, Piaggio G, Damasio MB, Molinelli C, Ferretti SM, Pistorio A, Ghiggeri G, Degl'Innocenti ML, Canepa A, Incarbone V, Mattioli G.
    J Pediatr Urol; 2018 Feb; 14(1):68.e1-68.e6. PubMed ID: 29133170
    [Abstract] [Full Text] [Related]

  • 13. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
    Gerber C, Harel M, Lynch ML, Herbst KW, Ferrer FA, Shapiro LH.
    J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
    [Abstract] [Full Text] [Related]

  • 14. Reoperative robotic pyeloplasty in children.
    Davis TD, Burns AS, Corbett ST, Peters CA.
    J Pediatr Urol; 2016 Dec; 12(6):394.e1-394.e7. PubMed ID: 27423387
    [Abstract] [Full Text] [Related]

  • 15. [Diagnosis and treatment of ureteropelvic junction obstruction caused by renal crossing vessels:an analysis of 24 cases].
    Qiu M, Wu H, Ma L, Lu J, Huang Y, Li G, Yan Y, Li H.
    Zhonghua Wai Ke Za Zhi; 2014 Sep; 52(9):702-5. PubMed ID: 25410785
    [Abstract] [Full Text] [Related]

  • 16. Laparoscopic Pyeloplasty for Ureteropelvic Junction Obstruction Following Open Pyeloplasty in Children.
    Powell C, Gatti JM, Juang D, Murphy JP.
    J Laparoendosc Adv Surg Tech A; 2015 Oct; 25(10):858-63. PubMed ID: 26488107
    [Abstract] [Full Text] [Related]

  • 17. Is routine postoperative diuresis renography indicated in all adult patients after pyeloplasty for ureteropelvic junction obstruction?
    Lam W, Fernando A, Issa R, Heenan S, Sandhu S, Le Roux P, Anderson C.
    Urology; 2015 Jan; 85(1):246-51. PubMed ID: 25530392
    [Abstract] [Full Text] [Related]

  • 18. Early pyeloplasty for recovery of parenchymal thickness in children with unilateral ureteropelvic junction obstruction.
    Kim SO, Yu HS, Hwang IS, Hwang EC, Kang TW, Kwon D.
    Urol Int; 2014 Jan; 92(4):473-6. PubMed ID: 24642503
    [Abstract] [Full Text] [Related]

  • 19. Elevated urinary lipocalin-2, interleukin-6 and monocyte chemoattractant protein-1 levels in children with congenital ureteropelvic junction obstruction.
    Yu L, Zhou L, Li Q, Li S, Luo X, Zhang C, Wu B, Brooks JD, Sun H.
    J Pediatr Urol; 2019 Feb; 15(1):44.e1-44.e7. PubMed ID: 30420258
    [Abstract] [Full Text] [Related]

  • 20. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
    Assadi F, Mazaheri M.
    J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.